Portfolio concentration
As of January 31, 2026 · N-PORT
Holdings
61
Top-10 weight
46.61%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
31
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
1149.7
Holdings
As of January 31, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | JOHNSON&JOHNSON | — | 2,868 | $651.75K | 7.43% |
| 2 | LILLY ELI and CO | — | 609 | $631.62K | 7.20% |
| 3 | ABBVIE INC | — | 2,129 | $474.79K | 5.41% |
| 4 | MERCK & CO | — | 4,066 | $448.36K | 5.11% |
| 5 | ASTRAZENECA PLC | — | 2,242 | $417.72K | 4.76% |
| 6 | NOVO NORDISK-B | — | 5,388 | $319.94K | 3.65% |
| 7 | UNITEDHEALTH GRP | — | 1,067 | $306.15K | 3.49% |
| 8 | DANAHER CORP | — | 1,268 | $277.55K | 3.16% |
| 9 | MEDTRONIC PLC | — | 2,643 | $272.12K | 3.10% |
| 10 | ROCHE HOLDINGS AG (GENUSSCHEINE) | — | 564 | $256.47K | 2.92% |
| 11 | BRISTOL-MYERS SQUIBB CO | — | 3,881 | $213.65K | 2.43% |
| 12 | BOSTON SCIENTIFIC CORP | — | 2,272 | $212.50K | 2.42% |
| 13 | CVS HEALTH CORP | — | 2,827 | $210.67K | 2.40% |
| 14 | MCKESSON CORP | — | 221 | $183.70K | 2.09% |
| 15 | ARGENX SE | — | 218 | $183.33K | 2.09% |
| 16 | REGENERON PHARMACEUTICALS INC | — | 247 | $183.14K | 2.09% |
| 17 | LONZA GROUP -REG | — | 252 | $171.22K | 1.95% |
| 18 | ESSILORLUXOTTICA | — | 551 | $168.44K | 1.92% |
| 19 | HOYA CORP | — | 1,000 | $167.76K | 1.91% |
| 20 | UCB SA | — | 544 | $165.77K | 1.89% |
| 21 | VERTEX PHARMACEUTICALS INC | — | 344 | $161.65K | 1.84% |
| 22 | STRYKER CORP | — | 406 | $150.04K | 1.71% |
| 23 | THERMO FISHER SCIENTIFIC INC | — | 254 | $146.97K | 1.67% |
| 24 | CARDINAL HEALTH INC | — | 679 | $145.90K | 1.66% |
| 25 | EDWARDS LIFESCIENCES CORP | — | 1,781 | $144.90K | 1.65% |
| 26 | IQVIA HOLDINGS INC | — | 544 | $125.20K | 1.43% |
| 27 | INTUITIVE SURGICAL INC | — | 235 | $118.49K | 1.35% |
| 28 | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | 3,182 | $107.96K | 1.23% |
| 29 | Fresenius SE & Company KGaA | FRE | 1,875 | $104.88K | 1.19% |
| 30 | Novartis AG (Registered) | NVSEF | 672 | $99.70K | 1.14% |
| 31 | Sartorius Aktiengesellschaft | SRT3 | 327 | $91.39K | 1.04% |
| 32 | BIOGEN INC | — | 460 | $82.75K | 0.94% |
| 33 | AXSOME THERAPEUTICS INC | — | 429 | $79.04K | 0.90% |
| 34 | IONIS PHARMACEUTICALS INC | — | 943 | $77.96K | 0.89% |
| 35 | APOGEE THERAPEUTICS INC | — | 1,116 | $73.11K | 0.83% |
| 36 | NEUROCRINE BIOSCIENCES INC | — | 498 | $67.76K | 0.77% |
| 37 | Ascendis Pharma A/S | — | 297 | $67.15K | 0.77% |
| 38 | GENMAB AS | — | 199 | $64.83K | 0.74% |
| 39 | UNITED THERAPEUTICS CORP DEL | — | 136 | $63.85K | 0.73% |
| 40 | IMMUNOME INC | — | 2,513 | $61.87K | 0.70% |
| 41 | DISC MEDICINE INC | — | 759 | $58.69K | 0.67% |
| 42 | DAIICHI SANKYO | — | 3,200 | $58.62K | 0.67% |
| 43 | VIRIDIAN THERAPEUTICS INC | — | 1,743 | $57.52K | 0.66% |
| 44 | DYNE THERAPEUTICS INC | — | 3,200 | $57.25K | 0.65% |
| 45 | CG ONCOLOGY INC | — | 1,052 | $54.76K | 0.62% |
| 46 | CONVATEC GROUP P | — | 16,261 | $51.29K | 0.58% |
| 47 | REVOLUTION MEDICINES INC | — | 455 | $44.11K | 0.50% |
| 48 | WATERS CORP | — | 116 | $43.00K | 0.49% |
| 49 | CYTOKINETICS INC | — | 679 | $42.91K | 0.49% |
| 50 | BIO-TECHNE CORP | — | 633 | $40.57K | 0.46% |
1 / 2
Next ›
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.